Pembrolizumab 12714-0091
Product NDC
12714-0091- Manufacturer
- Boehringer Ingelheim Pharma Gmbh And Co. Kg
- Dosage Form
- Liquid
- Product Type
- Drug For Further Processing
- Marketing Start
- December 1, 2016
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Pembrolizumab | 165 mg/mL |
Packaging Options(1)
16600 mL in 1 BAG (12714-091-99)